Skip to main content
Top
Published in:

Open Access 01-12-2025 | Chlamydia Trachomatis | Research

Cross-sectional study on the seroprevalence, reinfection, and associated factors of Chlamydia trachomatis among female sex workers in Guangdong Province, China

Authors: Peizhen Zhao, Lei Xu, Yinna Huang, He Huang, Junhe Chen, Weiming Tang, Lijun Mo, Qingqing Xu, Shujie Huang, Cheng Wang, Heping Zheng, Bin Yang, Yaohua Xue

Published in: BMC Infectious Diseases | Issue 1/2025

Login to get access

Abstract

Background

Female sex workers (FSWs) are at high risk of chlamydia infection, yet the seroprevalence among FSWs in China remains unclear. This study aimed to determine the seroprevalence of Chlamydia trachomatis and associated factors among FSWs in Guangdong Province, China.

Methods

A cross-sectional study was conducted among FSWs in two cities in Guangdong Province. Participants provided serum and urine samples. Nucleic acid amplification test (NAAT) was used to detect Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in urine samples. Enzyme-linked immunosorbent assay (ELISA) was used to detect chlamydia IgG antibodies in serum samples. Seropositivity was defined by IgG-positive results. Current chlamydia infection was identified by a positive NAAT result, while prior infection was indicated by positive chlamydia IgG and negative NAAT results. Reinfection was defined by positive results for both NAAT and chlamydia IgG. Moreover, positive ELISA results were reclassified into two categories: DU/mL values ≥ 37.89 (the median) were classified as high-positive and DU/mL values > 11 to 37.89 as low-positive. Sociodemographic data, CT and NG testing, and paper questionnaires were collected through face-to-face interviews. Univariate and multivariable logistic regressions explored factors associated with current CT infection.

Results

A total of 435 serum and urine samples were analyzed. The median age of the participants was 32.0 (IQR: 27.0–37.0) years. Among the participants, 326 were CT IgG positive, resulting in an overall seroprevalence of 74.9% (95% CI, 70.6–78.9). The current infection proportion determined by NAAT was 12.2% (53/435) (95% CI, 9.3–15.6), significantly lower than the IgG seroprevalence. Seroprevalence was higher among those over 39 years (88.6%) compared to those under 20 years (62.5%). High seroprevalence was observed among NAAT-negative participants (74.3%, 95% CI, 69.7–78.7). Single, divorced, or widowed individuals had higher seroprevalence (78.4%, 95% CI, 72.9–83.1) compared to married ones (69.5%, 95% CI, 61.9–76.3) (P < 0.05). Among seropositive participants, 42 were both NAAT and chlamydia IgG positive, indicating a reinfection proportion of 12.9% (95% CI, 9.4–17.0). Among reinfections, 81.0% had high seropositivity and 19.0% had low seropositivity. Reinfection prevalence was highest in those under 20 years (50%, 95% CI, 18.7–81.3) (P < 0.05).

Conclusion

This study found a high prevalence of anti-chlamydia IgG among FSWs, including those who were NAAT-negative. Additionally, there was a high reinfection proportion among Chinese FSWs. CT serological assays are increasingly recognized as valuable epidemiological tools. Younger FSWs and those new to transactional sex may be at higher risk and should be prioritized for community-based prevention interventions to reduce the burden of CT transmission. Overall, CT serological assays are increasingly recognized as valuable tools for epidemiological surveillance and intervention.

Clinical trial number

Not applicable.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Cross-sectional study on the seroprevalence, reinfection, and associated factors of Chlamydia trachomatis among female sex workers in Guangdong Province, China
Authors
Peizhen Zhao
Lei Xu
Yinna Huang
He Huang
Junhe Chen
Weiming Tang
Lijun Mo
Qingqing Xu
Shujie Huang
Cheng Wang
Heping Zheng
Bin Yang
Yaohua Xue
Publication date
01-12-2025
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2025
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-025-10650-x

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Watch the full video

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Log in / Register to watch the full video

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more